The Food and Drug Administration (FDA) has recently released two draft guidance documents (Artificial Intelligence-Enabled Device Software ...
The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...
Over the last week, digital health startups with an AI focus have announced impressive fundraises, setting the tone for the ...
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...
In this article, I share my take on the transformative potential of AI and ML in the modern care delivery process.
Scaling personalized therapies brings unique logistical challenges. Unlike mass-market drugs, these treatments require highly specific materials, stringent cold chain logistics and real-time ...
The industry's ability to establish effective governance hinges upon the ability to overcome the inherent challenges ...
The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.
Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.
BioSpace recaps 2024’s top venture capital rounds in biopharma, from Xaira Therapeutics’ blockbuster $1B raise to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback